Integral Diagnostics Director’s Indirect Shareholding Rises After Correction
IDX: $1.71 -2.85% · MC: $622M
Integral Diagnostics corrected its director-interest notice, confirming Andrew Fay indirectly acquired 60,000 shares through his spouse, bringing her reported holding to 107,000 shares. The correction replaces the original notice’s erroneous prior holding; Fay’s direct and superannuation-trust holdings were unchanged.

Comments